share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144：擬議出售證券
美股sec公告 ·  06/15 04:33
牛牛AI助理已提取核心訊息
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 06/14/2024, as announced in a recent filing. The shares, valued at an aggregate market value of $139,081.62, were acquired on 06/13/2023 through a stock option exercise, with the securities originally issued by the issuer. The transaction is part of a pre-planned trading activity that was adopted on 03/01/2023. This sale follows a series of transactions over the past three months where a total of 63,124 shares were sold by the officer.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 06/14/2024, as announced in a recent filing. The shares, valued at an aggregate market value of $139,081.62, were acquired on 06/13/2023 through a stock option exercise, with the securities originally issued by the issuer. The transaction is part of a pre-planned trading activity that was adopted on 03/01/2023. This sale follows a series of transactions over the past three months where a total of 63,124 shares were sold by the officer.
Recursion 藥品 公司官員 Secora Michael 計劃於 2024 年 06 月 14 日出售 15,000 股 A 級股票，該交易在最近的申報中公佈。這些股票的市場總價值爲 $139,081.62，是通過股票期權行權於 2023 年 06 月 13 日獲得，由發行人最初發行的有價證券。該交易是早在 2023 年 03 月 01 日就採用的預定交易活動的一部分。本次交易是官員在過去三個月內進行的一系列交易之後的銷售。
Recursion 藥品 公司官員 Secora Michael 計劃於 2024 年 06 月 14 日出售 15,000 股 A 級股票，該交易在最近的申報中公佈。這些股票的市場總價值爲 $139,081.62，是通過股票期權行權於 2023 年 06 月 13 日獲得，由發行人最初發行的有價證券。該交易是早在 2023 年 03 月 01 日就採用的預定交易活動的一部分。本次交易是官員在過去三個月內進行的一系列交易之後的銷售。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。